No Data
No Data
Earnings Preview: TNDM to Report Financial Results Post-market on April 30
$Tandem Diabetes Care(TNDM.US)$ is scheduled to release its financial results post-market on April 30 ET. Earnings PreviewAnalysts estimate $Tandem Diabetes Care(TNDM.US)$ to post revenue of USD220.22
Shares of Diabetes Stocks Are Trading Lower Following Successful Obesity Data From Lilly.
Express News | Diabetes Device Makers' Shares Down After Eli Lilly's Pill Leads to Weight Loss in Late-Stage Trial
Barclays Names Most and Least Affected Healthcare Companies From Tariffs
RBC Capital Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Cuts Target Price to $45
RBC Cuts Price Target on Tandem Diabetes Care to $45 From $55, Keeps Outperform Rating